Factors that could cause actual results to differ materially from those implied by these forward looking statements include but are not limited to:• Factors that could cause actual results to differ materially from those implied by these forward‐looking statements include, but are not limited to:  Our ability to achieve the strategic and other objectives relating to the Spartech acquisition, including any expected synergies; our ability to successfully  integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and  cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate  liquidity) to maintain their credit availability;liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The amount and timing of repurchases, if any, of PolyOne common shares and our ability to pay regular quarterly cash dividends and the amounts and  timing of any future dividends;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;g p y p g ;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital  reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;, , p y p y g , y p p ;  An inability to maintain appropriate relations with unions and employees; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and  changes in the rate of inflation. • The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward‐looking statements, whether as a result of new information, future events or otherwise.   EPS: $1.20 Proforma Debt Maturities & Liquidity Summary – 12/31/12 (Reflecting  Financing & Spartech Acquisition) • Total Debt at 12/31/12 h $1,010 $297 $360 $300 $400 Debt Maturities  As of December  31, 2012  ($ millions) Less: Cash Net Debt 213 $797 $50 $297 $100 $200 • Available Liquidity Cash $213 $800 Debt Maturities  As of December  31, 2012 P f f 2/13 Fi i $50 $0 2015 2017 2020 Interest Rates: 7.500%                       5.000%                      7.375% Cash ABL Availability Total Liquidity $213 271 $484 $600 $400 $600 Proforma for 2/13 Financing ($ millions) Total Liquidity • Net Debt / EBITDA = 2.0x* $484 $50 $360 $0 $200 • Net Debt / EBITDA = 2.35x** $50$0 2015 2020 2023 Page 14 Interest Rates:   7.500%                      7.375%                      5.250% *Assumes $65 million of synergies related to Spartech acquistion **Assumes no synergies related to Spartech acquistion Use of Cash Share DividendsOrganic G Acquisitions • Repurchased 1 2 Repurchase • Introduced a Dividends • Expanding our Growth T t th t d Acquisitions • Repurchased 1.2 million shares in 2012 • 20.0 million shares are il bl f • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Expanding our sales, marketing, and technical capabilities is top priority • Investing in • Targets that expand our: • Specialty offering • End market presence • Geographic footprint available for repurchase under the current authorization Q1 2013 (20%) • Objective of maintaining and growing Investing in operational and LSS initiatives (including synergy capture) • CAPEX • Synergy opportunities • Adjacent material solutions Proforma Cash Balance = $213M N t D bt / EBITDA* 2 0X CAPEX Net Debt / EBITDA* = 2.0X *Adjusted EBITDA assumes synergies related to the Spartech acquisition are realized at close; preliminary synergies estimated at $65M and are expected to be achieved over a 3-year period Page 15 Why Invest In PolyOne? Strong past performance demonstrates that our  strategy and execution are workinggy g • Megatrends align with our strengths • Innovation and services provide differentiation  and competitive advantage • Strong and proven management team driving  growth and performancegrowth and performance The New PolyOne: A Specialty Growth Company $2015 Target: $2.50 Adjusted EPS Page 16 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S.

Select from overt or covert solutions, available for a wide range of polymers. Nomex® Meta-Aramid

Solutions are available for various carrier systems, including: Nomex® Meta-Aramid

Liquid concentrates are also available as well as solutions formulated with bio-based resins to reduce the carbon footprint of medical plastics. Nomex® Meta-Aramid

A variety of polymer additives are available to help eliminate unwanted visual reactions such as fogging or scratching, while other additive technologies can improve processing or end-use functionality. Nomex® Meta-Aramid

Liquid color concentrates available for certain polymers Nomex® Meta-Aramid

These dispersions are available for silicone, latex, vinyl and various thermoset applications. Nomex® Meta-Aramid

Available in various physical forms for different manufacturing processes, the perfect masterbatch for your product is closer than you think. Nomex® Meta-Aramid

The slide presentations will be made available on this site as well, at the onset of the event. http://www.avient.com/investors 2 About Avient Avient Corporation (NYSE: AVNT), with expected 2021 revenues of $4.75 billion, provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. Rose Vice President, Corporate Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com http://www.avient.com/ http://www.avient.com/news mailto:giuseppe.disalvo@avient.com mailto:kyle.rose@avient.com NEWS RELEASE

NYSE: AVNT), a leading provider of specialized and sustainable material solutions, has published its most recent Sustainability Report, available at www.avient.com/sustainability. Increased data and transparency in key ESG areas, such as environmental data, safety performance and employee demographics